Investigational drug · Phase 3
AG20012
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Acute Bronchitis.
Phase 3Last checked: Nov 19, 2026Latest source record: Sep 30, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "AG20012"
First trial start
2025
Nov 1, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "AG20012", any sponsor or status.
Conditions studied
As listed on its trial records.
- Acute Bronchitis
Largest trials
Live from ClinicalTrials.gov: studies naming "AG20012" as an intervention, largest first.
- Efficacy and Safety of AG2001 in Patients With Acute BronchitisPivotal-lookingNot yet recruiting
Ahn-Gook Pharmaceuticals Co.,LtdIndustry
NCT07198347 · 300 participants (planned) · Start Nov 1, 2025 · Primary completion Mar 31, 2026
Drug: AG2001; AG20011 and 1 more · For: Acute Bronchitis
Newest research
PubMed records naming it or its code names, newest first.
- Pharmacokinetics, tolerability and cycle control of three transdermal contraceptive delivery systems containing different doses of ethinylestradiol and levonorgestrel.
Stanczyk FZ, Rubin A, Flood L, et al. · Horm Mol Biol Clin Investig 2011
Also in development for Acute Bronchitis
- RaphaminMMH-407Phase 35 trials
Materia Medica Holding · Rhinosinusitis, Rhinosinusitis Acute, Cystitis Chronic
- AG2001Phase 31 trial
Ahn-Gook Pharmaceuticals Co.,Ltd · Acute Bronchitis
- AG20011Phase 31 trial
Ahn-Gook Pharmaceuticals Co.,Ltd · Acute Bronchitis
- DW5121Phase 31 trial
Daewon Pharmaceutical Co., Ltd. · Acute Bronchitis
- DW51211Phase 31 trial
Daewon Pharmaceutical Co., Ltd. · Acute Bronchitis
- DW51212Phase 31 trial
Daewon Pharmaceutical Co., Ltd. · Acute Bronchitis
- YHP2401Phase 31 trial
Yuhan Corporation · Acute Bronchitis
- YHR2402Phase 31 trial
Yuhan Corporation · Acute Bronchitis
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.